David Stegner: How Fundamental Platelet Research Can Translate Into Therapeutic Innovation
David Stegner, Professor of Vascular Imaging at the Julius Maximilians University of Würzburg, reposted from Boehringer Ingelheim on LinkedIn:
”A strong example of how fundamental platelet research can translate into therapeutic innovation.
Work from University Hospital of Würzburg has identified GPVI as a key driver of thrombo-inflammation in acute ischemic stroke, directly linking platelet biology to clinical outcome.
The collaboration between Boehringer Ingelheim and Emfret Analytics now advances this concept toward clinical application.
Targeting GPVI offers a compelling strategy: inhibiting pathological platelet activation while preserving hemostasis – a critical requirement in stroke therapy.
For the field, this marks an important translational milestone.
For patients, it highlights the potential to improve outcomes beyond current standard-of-care.”
Quoting Boehringer Ingelheim‘s post:
”NEWS: We are collaborating with Emfret Analytics to advance a potential first‑in‑class antibody‑based approach for acute ischemic stroke.
For decades, we have helped transform stroke care.
By targeting the platelet receptor GPVI, this new approach aims to inhibit thrombus formation and growth while maintaining normal hemostasis – designed to complement standard‑of‑care therapies and further improve patient outcomes.”
Stay updated with Hemostasis Today.
-
Apr 7, 2026, 16:02Support the WHO Resolution On Stroke and Set A Clear Path to Action – World Stroke Organization
-
Apr 7, 2026, 16:00Amit Saraswat: The Role of Physiotherapy in Regaining Independence In Stroke Recovery
-
Apr 7, 2026, 15:58Armghan Ans: The 2026 Stroke Guidelines and the Clinical Logic Gap in AI Tools
-
Apr 7, 2026, 15:55Louise St. Germain Bannon: A Call to Advance Health Equity for Women on World Health Day
-
Apr 7, 2026, 15:54Emicizumab In a Preterm Infant with Severe Hemophilia A – RPTH
-
Apr 7, 2026, 15:45Alejandro Lusilla Lopez: PRF for Complex Anal Fistulae Outcomes
-
Apr 7, 2026, 15:41Edwin Ofori Atta: High-Dose Vitamin C and Vascular Function
-
Apr 7, 2026, 15:32Brad McEwen: Dark Chocolate and Cardiometabolic Health
-
Apr 7, 2026, 14:50Sean O.: The Urgent Need for Blood in the United States